Business
Abattis (ATTBF) Targets Emerging Markets with Nutraceutical Business -- CFN Media
Abattis (ATTBF) Targets Emerging Markets with Nutraceutical Business -- CFN Media.
About this update from Abattis Bioceuticals Corp
[{"type":"text","content":"\n \n \n Abattis (ATTBF) Targets Emerging Markets with Nutraceutical Business -- CFN Media\n \n \nAbattis (ATTBF) Targets Emerging Markets with Nutraceutical Business -- CFN Media\n \n SEATTLE, WA--(Marketwired - Nov 28, 2016) - CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article covering Abattis Bioceuticals Corp.'s (OTCQB: ATTBF) (CSE: ATT) recent expansion of distribution lines in Asia and how those efforts complement the company's other business lines.\n Abattis Bioceuticals is best-known for its Northern Vine Labs™ subsidiary that aims to become a leading cannabis testing and formulation facility, but its Vergence Sales & Marketing Group subsidiary is expected to contribute just as much revenue next year. With the establishment of contractual relationships in Asia in Q3 and Q4 of fiscal 2016, the Vergence subsidiary dovetails nicely with its Northern Vine subsidiary as it moves into the formulation business.\n Abattis Bioceuticals' Vergence subsidiary consists of a team of bioceutical marketing specialists focused on cultivating natural, safe, and effective health products. Initially, the company will focus on products that reduce pain caused by inflammation, boost immunity, and increase nutrient absorption. Natural remedies have the potential to address these issues without the need to resort to pharmaceuticals and lengthy clinical trials.\n The company plans to build a portfolio of natural formulations and innovative brands that enhance quality of life. Currently, Vergence's brands include Noxx™ Botanical Blends, Comfort White Willow Blend, Soothe Ginseng Root Blend, Sassy™, and Phyto[NOS]™ Nitric Oxide Production. Over time, the company plans to develop new products that it can sell into numerous end markets around the world.\n Vergence complements the company's Northern Vine subsidiary. With plans to formulate hemp-derived cannabinoids, Northern Vine will enable the sales and marketing arm to introduce innovative new products into a hot market. Hemp-based CBDs, for example, have become extremely popular as the medicinal benefits of the hemp plant become more apparent. According to The CBD Report, recently published by The Hemp Business Journal, the U.S. hemp-derived CBD market will total about $115 million...